Autologous activated fibrin sealant for the esophageal anastomosis: a feasibility study

Victor D. Plat, Boukje T. Bootsma, Nicole van der Wielen, Donald L. van der Peet, Freek Daams

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Esophageal cancer is surgically treated by means of an esophagectomy. However, esophagectomies are associated with high morbidity rates with dehiscence of the anastomosis occurring in 19% of these procedures in the Netherlands. Application of a fibrin sealant may improve mechanical strength of the anastomosis. The aim of this study was to determine the technical feasibility of the application of an autologous fibrin sealant by aerosolized spraying on esophageal anastomoses. Methods: This study was designed as a single-center feasibility study. Patients undergoing elective minimal invasive esophageal surgery with the creation of a thoracic or a cervical anastomosis were eligible. Fibrin sealant (Vivostat) was applied to the anastomosis intraoperatively. Feasibility was measured using a nine-item checklist, designed for intraoperative application. Results: In total, fifteen patients, between the ages of 43-79 y, were included in this study. One procedure scored eight out of nine points on the feasibility checklist, so application was considered as unsuccessful. The other fourteen procedures obtained a 100% score and were documented as successful procedures. Together, this led to a success rate of 93%. Grade III anastomotic leakage occurred in one of the fifteen patients (6.7%). Conclusions: This study showed that application of fibrin sealant on esophageal anastomoses is technically feasible and safe. Future studies may investigate the possible protective effects of fibrin sealant application on the development of anastomotic leakage. NCT03251040.
LanguageEnglish
Pages49-53
JournalJournal of Surgical Research
Volume234
DOIs
StatePublished - 2019

Cite this

@article{4bfbf5c980a24254bc7e5a6b5e11db0b,
title = "Autologous activated fibrin sealant for the esophageal anastomosis: a feasibility study",
abstract = "Background: Esophageal cancer is surgically treated by means of an esophagectomy. However, esophagectomies are associated with high morbidity rates with dehiscence of the anastomosis occurring in 19{\%} of these procedures in the Netherlands. Application of a fibrin sealant may improve mechanical strength of the anastomosis. The aim of this study was to determine the technical feasibility of the application of an autologous fibrin sealant by aerosolized spraying on esophageal anastomoses. Methods: This study was designed as a single-center feasibility study. Patients undergoing elective minimal invasive esophageal surgery with the creation of a thoracic or a cervical anastomosis were eligible. Fibrin sealant (Vivostat) was applied to the anastomosis intraoperatively. Feasibility was measured using a nine-item checklist, designed for intraoperative application. Results: In total, fifteen patients, between the ages of 43-79 y, were included in this study. One procedure scored eight out of nine points on the feasibility checklist, so application was considered as unsuccessful. The other fourteen procedures obtained a 100{\%} score and were documented as successful procedures. Together, this led to a success rate of 93{\%}. Grade III anastomotic leakage occurred in one of the fifteen patients (6.7{\%}). Conclusions: This study showed that application of fibrin sealant on esophageal anastomoses is technically feasible and safe. Future studies may investigate the possible protective effects of fibrin sealant application on the development of anastomotic leakage. NCT03251040.",
author = "Plat, {Victor D.} and Bootsma, {Boukje T.} and {van der Wielen}, Nicole and {van der Peet}, {Donald L.} and Freek Daams",
year = "2019",
doi = "10.1016/j.jss.2018.08.049",
language = "English",
volume = "234",
pages = "49--53",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",

}

Autologous activated fibrin sealant for the esophageal anastomosis: a feasibility study. / Plat, Victor D.; Bootsma, Boukje T.; van der Wielen, Nicole; van der Peet, Donald L.; Daams, Freek.

In: Journal of Surgical Research, Vol. 234, 2019, p. 49-53.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Autologous activated fibrin sealant for the esophageal anastomosis: a feasibility study

AU - Plat,Victor D.

AU - Bootsma,Boukje T.

AU - van der Wielen,Nicole

AU - van der Peet,Donald L.

AU - Daams,Freek

PY - 2019

Y1 - 2019

N2 - Background: Esophageal cancer is surgically treated by means of an esophagectomy. However, esophagectomies are associated with high morbidity rates with dehiscence of the anastomosis occurring in 19% of these procedures in the Netherlands. Application of a fibrin sealant may improve mechanical strength of the anastomosis. The aim of this study was to determine the technical feasibility of the application of an autologous fibrin sealant by aerosolized spraying on esophageal anastomoses. Methods: This study was designed as a single-center feasibility study. Patients undergoing elective minimal invasive esophageal surgery with the creation of a thoracic or a cervical anastomosis were eligible. Fibrin sealant (Vivostat) was applied to the anastomosis intraoperatively. Feasibility was measured using a nine-item checklist, designed for intraoperative application. Results: In total, fifteen patients, between the ages of 43-79 y, were included in this study. One procedure scored eight out of nine points on the feasibility checklist, so application was considered as unsuccessful. The other fourteen procedures obtained a 100% score and were documented as successful procedures. Together, this led to a success rate of 93%. Grade III anastomotic leakage occurred in one of the fifteen patients (6.7%). Conclusions: This study showed that application of fibrin sealant on esophageal anastomoses is technically feasible and safe. Future studies may investigate the possible protective effects of fibrin sealant application on the development of anastomotic leakage. NCT03251040.

AB - Background: Esophageal cancer is surgically treated by means of an esophagectomy. However, esophagectomies are associated with high morbidity rates with dehiscence of the anastomosis occurring in 19% of these procedures in the Netherlands. Application of a fibrin sealant may improve mechanical strength of the anastomosis. The aim of this study was to determine the technical feasibility of the application of an autologous fibrin sealant by aerosolized spraying on esophageal anastomoses. Methods: This study was designed as a single-center feasibility study. Patients undergoing elective minimal invasive esophageal surgery with the creation of a thoracic or a cervical anastomosis were eligible. Fibrin sealant (Vivostat) was applied to the anastomosis intraoperatively. Feasibility was measured using a nine-item checklist, designed for intraoperative application. Results: In total, fifteen patients, between the ages of 43-79 y, were included in this study. One procedure scored eight out of nine points on the feasibility checklist, so application was considered as unsuccessful. The other fourteen procedures obtained a 100% score and were documented as successful procedures. Together, this led to a success rate of 93%. Grade III anastomotic leakage occurred in one of the fifteen patients (6.7%). Conclusions: This study showed that application of fibrin sealant on esophageal anastomoses is technically feasible and safe. Future studies may investigate the possible protective effects of fibrin sealant application on the development of anastomotic leakage. NCT03251040.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053938976&origin=inward

U2 - 10.1016/j.jss.2018.08.049

DO - 10.1016/j.jss.2018.08.049

M3 - Article

VL - 234

SP - 49

EP - 53

JO - Journal of Surgical Research

T2 - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

ER -